Introduction
Vision changes caused by retinal diseases can significantly affect daily life, independence, and long-term quality of life. Conditions such as wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) may lead to progressive vision loss if left untreated. For many patients, ongoing retinal treatment and monitoring become an important part of preserving vision and maintaining eye health.
Beovu is a biologic anti-VEGF medication used to help treat certain retinal diseases involving abnormal blood vessel growth and fluid leakage in the eye. The medication is administered directly into the eye by a trained ophthalmologist or retina specialist in a controlled clinical setting.
Wet AMD and diabetic macular edema occur when abnormal blood vessels and fluid buildup damage the retina, which is the light-sensitive tissue responsible for clear vision. Beovu works by blocking vascular endothelial growth factor (VEGF), a protein that contributes to this abnormal blood vessel growth and leakage.
By reducing VEGF activity, Beovu may help decrease retinal swelling, reduce fluid accumulation, and slow further vision damage in some patients. Clinical studies demonstrated strong retinal fluid reduction and maintenance of vision outcomes in many treated individuals.
One potential advantage for some patients is the possibility of extended dosing intervals after the initial treatment phase. Depending on disease response and provider assessment, some patients may require injections less frequently during maintenance therapy.
Although Beovu may provide important benefits for retinal disease management, specialty ophthalmology biologic medications can also create financial concerns. Patients may face costs related to injections, ophthalmology clinic visits, retinal imaging, and ongoing monitoring throughout treatment.
To help alleviate the financial burden when it comes to specialty medication costs, Prescription Hope offers access to affordable brand-name medications at a simple service fee of $70.00 per month, per medication. Those looking for affordable medication may benefit from Prescription Hope’s access to a patient assistance program.
Understanding how Beovu works, possible treatment benefits, side effects, and available medication access resources can help patients feel more informed when discussing retinal treatment options with their eye care specialist.
What Is the Beovu Patient Assistance Program?
Patients looking for affordable medication may benefit from the Beovu Patient Assistance Program. Those who need anti-VEGF medication assistance and qualify are provided access to low-cost Beovu.
Due to the expensive nature of some brand-name medications, such as specialty medications, pharmaceutical manufacturers have developed special programs to help patients who qualify. Patient Assistance Programs give patients who are struggling financially the opportunity to get access to their much-needed medications at low or no cost.
However, these programs have been known to be difficult to navigate and end up leaving patients feeling frustrated and overwhelmed.
Thankfully, there is a way patients can get peace of mind and focus on their treatment and loved one, not their medication costs or applying for complicated programs.
How Expert Advocates Help Make Beovu More Affordable
Professional Application Management
Prescription Hope advocates on patients’ behalf with patient assistance programs. We manage the application process, including completing forms, collecting documents and signatures, and coordinating with manufacturers.
Predictable Monthly Pricing
Our pricing remains $70.00 per month, per medication. Not only does that mean no hidden fees or surprise charges, but it also means no added medication costs.
Beovu Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Ongoing Advocacy and Refill Support
After your initial shipment of medication comes directly from the manufacturer, we continue to manage your refill scheduling, document updates, yearly renewals, and more.
Beovu Patient Assistance Eligibility
Patient assistance programs and their medication assistance gives patients support for their medication costs.
However, every patient assistance program maintains eligibility requirements. All programs have requirements that fall in several general categories. Some of those include:
Income level: Each program has its own income threshold criteria.
Insurance status: Each program maintains its own insurance coverage status requirement.
Prescription: Every program requires applicants to have a valid and current prescription for the brand-name medication they’re applying for.
U.S. Resident: All applicants must be U.S. residents to qualify.
Simple Enrollment With Expert Support
Starting Your Journey
If you wish to enroll in medication cost assistance and need ophthalmology medication support, then be sure to enroll with Prescription Hope. We’ll help you apply for the Beovu Patient Assistance Program. Our process takes only 6 steps:
- Submit Information: Take a few minutes and fill out our online enrollment form. Submit your completed form.
- Advocate Contact: Advocates contact patients 1-2 business days after submitted forms.
- Document Collection: Following prequalification, our team collects the needed documents.
- Provider Coordination: Not only that, but we’ll gather all necessary signatures from healthcare providers.
- Program Submission: Once everything is in order, we submit your application packet to the manufacturer and continue to follow up.
- Medication Delivery: After a patient is accepted into the program, they can typically expect their medication to ship within 2 weeks, directly from the manufacturer to their door or doctor’s office.
Please note, Prescription Hope is not a pharmacy or manufacturer. We do not handle medications at any time, and all shipments will come from the manufacturer and ship directly to your door or doctor’s office.
Medication Delivery and Ongoing Support
After you receive your medication, we’ll continue to manage your refill schedule, document updates, and yearly renewals.
Understanding Beovu
How Beovu Works
Beovu works by blocking vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel growth and fluid leakage in the retina.
In retinal diseases such as wet age-related macular degeneration and diabetic macular edema, excess VEGF activity contributes to swelling, fluid accumulation, and retinal damage that may lead to vision loss over time.
By inhibiting VEGF activity, Beovu may help:
- Reduce retinal swelling
- Decrease fluid leakage in the retina
- Slow progression of vision damage
- Help maintain or improve vision in some patients
The medication is classified as an anti-VEGF biologic therapy and is administered as an intravitreal injection directly into the eye by a trained ophthalmologist or retina specialist.
Patients receiving Beovu typically undergo ongoing retinal imaging and eye examinations throughout treatment to monitor disease response and detect complications.
What Conditions Does Beovu Treat?
Beovu is FDA-approved for the treatment of:
- Neovascular (wet) age-related macular degeneration (wet AMD)
- Diabetic macular edema (DME)
Wet AMD is a retinal disease involving abnormal blood vessel growth beneath the retina, which can lead to bleeding, fluid leakage, and progressive vision loss.
Diabetic macular edema occurs when diabetes-related blood vessel damage causes fluid buildup in the retina, leading to swelling and vision impairment.
Both conditions can significantly affect central vision and daily functioning if left untreated. Healthcare providers evaluate retinal imaging results, vision changes, disease severity, and overall eye health when determining whether Beovu may be an appropriate treatment option.
Benefits of Treatment
For some patients with retinal eye disease, Beovu may provide important treatment benefits by helping control retinal fluid buildup and slowing the progression of vision loss.
Potential benefits of Beovu treatment may include:
- Reduction in retinal fluid accumulation
- Slowing progression of vision damage
- Maintenance of vision outcomes in many patients
- Visual acuity improvements in some treated individuals
- Longer dosing intervals for some patients following initial treatment
- Reduction in disease-related retinal changes associated with wet AMD and DME
Clinical studies demonstrated effectiveness in controlling retinal fluid and maintaining vision outcomes in many patients receiving Beovu treatment.
Treatment response varies depending on disease severity, retinal health, treatment adherence, and individual patient factors. Ongoing ophthalmic monitoring is important throughout therapy.
Important Safety Information and Side Effects
Like all intravitreal eye injections, Beovu may cause side effects and carries important safety considerations. Patients should discuss the risks and benefits of treatment with their ophthalmologist before beginning therapy.
One important safety concern involves retinal vasculitis and retinal vascular occlusion, which have been reported following Beovu administration and may lead to severe vision loss in rare cases.
Patients should immediately contact their healthcare provider if they experience symptoms such as:
- Worsening vision
- Eye pain
- Light sensitivity
- Eye redness
- Sudden floaters
Common side effects associated with Beovu may include:
- Blurred vision
- Eye pain
- Eye redness
- Floaters
- Cataract formation
- Increased intraocular pressure
- Eye inflammation
Injection-related discomfort may also occur following administration.
Additional serious safety concerns may include:
- Intraocular inflammation
- Endophthalmitis (serious eye infection)
- Retinal detachment
- Increased intraocular pressure after injection
- Arterial thromboembolic events, such as stroke or heart attack, are uncommon
Proper sterile injection technique is important to help reduce the risk of serious eye infections and complications.
Beovu should not be used in patients with active eye infections or active intraocular inflammation.
Patients with a history of stroke or cardiovascular disease should discuss potential risks with their healthcare provider because systemic anti-VEGF effects may occur.
Regular ophthalmic monitoring, including retinal imaging and eye examinations, is typically required throughout treatment to assess retinal response and detect complications early.
Beovu does not currently carry an FDA boxed warning.
Access to Multiple Medications
Need specialty medication assistance for more than one brand-name medication? Looking to save on other medications the same way you’re getting retinal disease treatment support?
Prescription Hope can help. No matter how many medications you qualify for, we can help.
Our service fee remains a simple $70.00 per month, per medication. No hassle, no hidden fees, no extra charges. Plus, you won’t have any added medication costs!
Why Choose Prescription Hope for Beovu Assistance
Experienced Advocacy Support
For 20 years, Prescription Hope has provided patients across the U.S. with excellent service and compassionate support. We don’t just handle your application and manage your medication access – we want to help you have peace of mind and a high quality of life.
Ongoing Medication Management
We know the details of medication access management can be a burden, especially for those dealing with serious conditions.
To help alleviate the pressure, we manage patients’ refill schedules, document updates, program monitoring, yearly renewals, and more. All so you don’t have to.
Transparent Monthly Pricing
Our service rate remains a simple $70.00 per month, per medication. No hassles. No surprises.
Nationwide Medication Access Support
For 20 years, our network has grown to over 180 pharmaceutical manufacturers and tens of thousands of healthcare providers.
With a list of hundreds of brand-name medications, we want to help you get access to the medications you need.
If you’re looking to enroll in a patient assistance program through Prescription Hope, then be sure to fill out our enrollment form today!
